Compare LUCD & HAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LUCD | HAVA |
|---|---|---|
| Founded | 2018 | 2024 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 192.9M | 209.0M |
| IPO Year | 2021 | 2025 |
| Metric | LUCD | HAVA |
|---|---|---|
| Price | $0.40 | $10.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 7.8M | 79.4K |
| Earning Date | 11-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,346,000.00 | N/A |
| Revenue This Year | $34.40 | N/A |
| Revenue Next Year | $191.30 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 79.00 | N/A |
| 52 Week Low | $0.30 | $9.90 |
| 52 Week High | $1.63 | $10.30 |
| Indicator | LUCD | HAVA |
|---|---|---|
| Relative Strength Index (RSI) | 39.70 | 68.54 |
| Support Level | $0.30 | $9.98 |
| Resistance Level | $0.48 | $10.30 |
| Average True Range (ATR) | 0.04 | 0.00 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 8.03 | 83.33 |
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Harvard Ave Acquisition Corp is a blank check company.